Orasis Pharmaceuticals raised €25M in a funding round in Sep 2020. The company is based in Herzliya, Israel. Investors in the round: Bluestem Capital, Visionary Venture Fund. Data as of 21 Sept 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
